Rock. RATIONALE: Eighty percent of children with asthma exacerbations will have an associated viral infection. Defining the local inflammatory mediators that may lead to exacerbations can provide targets for future therapies. We hypothesized that nasal periostin is higher in exacerbating asthmatics with viral infections and that this level correlates with symptom severity during acute viral-induced exacerbations of asthma. METHODS: We recruited 97 patients (exacerbating asthma n 5 69, controls 5 28) with upper respiratory infection symptoms from the Emergency Department. Baseline Pediatric Respiratory Symptoms (PRS) Scores were recorded. Nasopharyngeal swabs were used to detect the presence of virus by viral genome sequencing. Nasal filter paper was used to collect nasal mucosal lining fluid, and after elution, inflammatory mediators were analyzed using bead-array immunoassay. RESULTS: Asthmatics expressed higher nasal periostin compared to controls (means517.37pg/mL, 5.86pg/mL respectively; p<0.05). Those asthmatics with viral infections and moderate/severe symptoms by PRS had more periostin than asthmatics with viral infections and mild symptoms (means522.5pg/mL, 12.30pg/mL, respectively; p<0.05). Among asthmatics with moderate/severe symptoms, there was no difference between those with and without viruses. In all asthmatics, acute symptoms correlated with periostin levels (R 2 5 0.2, p < 0.05). Periostin levels were higher in asthmatics with personal history of allergic rhinitis (AR) compared to asthmatics without AR (means520.19pg/mL, 4.71pg/ mL, respectively; p<0.05). CONCLUSIONS: Nasal periostin levels are higher in asthmatics and are increased with moderate/severe symptoms during viral-induced asthma exacerbations. Nasal periostin levels likely represent host Th2 endotype rather than exposure to virus during asthma exacerbations.
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The RATIONALE: Resuspension of dust from carpet is an important source of microbial, chemical, and allergen exposure in the indoor built environment. Carpet constitutes 51% of the total US flooring market according to the Carpet and Rug Institute. However, it remains to be determined if the presence of carpet in a home affects the fungal and bacterial species composition and if factors such as relative humidity (RH) influence the indoor microbiome. METHODS: We examined the effects of carpet on the indoor microbiome in both an epidemiological study and a laboratory chamber study. Samples (n5506) were collected from the bedroom floors of participants in the NYC Neighborhood Asthma and Allergy Study (NAAS). Additionally, carpets from 17 homes in Ohio were collected and incubated at 50%, and then raised to 85% or 100% RH for a period of 0, 6, 12, 18, or 24 hours per day over two weeks. RESULTS: In the NAAS samples, the presence of carpet was associated with changes in fungal communities (P50.00002), and 205 fungal species were more prevalent in homes with carpet compared to those without. In chambers, RH fluctuations resulted in fungal growth in the carpet, which could be modeled using the time-of-wetness concept (Pearson Correlation Coefficients 0.964 for 100% RH and 0.937 for 85% RH). Microscopic imaging revealed fungal hyphae and fruiting bodies attached to carpet fibers. CONCLUSIONS: Our results indicate that the presence of carpet in homes likely alters the indoor microbiome and human exposure to microbes. Other factors such as RH levels may also influence this exposure.
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Monoclonal Antibodies Define Multiple Epitopes on Major Dust Mite Allergen, Der p 23 Bryan R. E. Smith, Kristina Reid Black, Stephanie Filep, and Martin D. Chapman, PhD FAAAAI; Indoor Biotechnologies, Inc., Charlottesville, VA. RATIONALE: House dust mites are one of the most common sources of indoor allergens, affecting more than 100 million people worldwide. Der p 23, an allergen produced by Dermatophagoides pteronyssinus, has recently been identified as a major allergen, with a sensitization rate of nearly 75% amongst mite allergic patients. Our goal was to develop monoclonal antibodies (mAb) to Der p 23 and to analyze their epitope specificity. METHODS: A panel of murine mAb were raised from mice immunized with recombinant Der p 23. Antibody-antigen affinity and binding kinetics were determined using bio-layer interferometry (Octet). Rabbit polyclonal antibodies were also produced using recombinant Der p 23 as immunogen. RESULTS: Eight highly reactive anti-Der p 23 mAb were analyzed by Octet to determine Der p 23 affinity, binding kinetics, and epitope specificity. Two mAb recognized a unique epitope on Der p 23 and paired with the remaining six mAb, which recognized a common epitope. Three mAb with the greatest potential for pairing in a two-site ELISA had binding affinities of 5.98E-08 to 6.20E-10 molar. Purified polyclonal antibody reacted strongly with Der p 23, having a titer >1:500,000. CONCLUSIONS: High affinity murine mAb and polyclonal rabbit antibody have been raised against Der p 23. The mAb recognize multiple epitopes and provide essential tools for immune-localization studies, for immunoassay development and for standardization of diagnostic and therapeutic dust mite allergenic products.
